BIOCHEMICAL PROFILING OF BLOOD AND BODY FLUIDS IN TUBERCULOSIS PATIENTS

This study aims to investigate the biochemical alterations in blood and body fluids of patients diagnosed with tuberculosis (TB), focusing on identifying potential biomarkers that reflect the disease's severity and progression. A total of [insert number] participants were recruited, comprising [insert number] confirmed TB patients and [insert number] healthy controls. Blood and body fluid samples, including pleural fluid and cerebrospinal fluid (CSF), were collected for analysis. Key biochemical parameters, such as serum electrolytes, liver and kidney function markers, inflammatory cytokines, and metabolic indicators, were measured using standardized laboratory techniques.

The results demonstrated significant deviations in the biochemical profiles of TB patients compared to healthy controls. Notably, elevated levels of inflammatory markers, including C-reactive protein (CRP) and interleukin-6 (IL-6), were observed, correlating with disease severity and extent of lung involvement. Liver function tests revealed increased levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), indicating hepatic stress in TB patients. Moreover, analysis of body fluids showed distinct biochemical signatures, with pleural fluid exhibiting higher concentrations of proteins and specific cytokines compared to serum, suggesting localized inflammatory responses.

These findings highlight the importance of biochemical profiling in understanding the pathophysiological changes associated with tuberculosis. The identified biomarkers could serve as valuable tools for early diagnosis, monitoring treatment response, and assessing disease prognosis. Ultimately, this study contributes to the growing body of evidence supporting the role of biochemical alterations in the management and understanding of tuberculosis, paving the way for future research into targeted therapeutic strategies.